US2013028921A1PendingUtilityA1

Composition comprising coumestrol or a bean extract containing coumestrol

Assignee: AMOREPACIFIC CORPPriority: Mar 31, 2010Filed: Mar 31, 2011Published: Jan 31, 2013
Est. expiryMar 31, 2030(~3.7 yrs left)· nominal 20-yr term from priority
A61P 3/06A61P 9/12A61P 9/10A61P 9/00A61P 37/04A61P 3/10A61P 37/02A61P 39/02A61P 25/16A61P 25/34A61P 25/28A61P 3/00A61P 3/04A61P 27/06A61P 21/04A61P 25/00A61P 1/16A61K 36/48A61K 31/35A61K 31/366A61K 36/484
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a composition which comprises as an active ingredient coumestrol or a bean extract containing coumestrol, whereby adipocyte differentiation is inhibited, the immune system of the body is improved, toxic substances are purged, and neurodegenerative disorders are prevented or improved.

Claims

exact text as granted — not AI-modified
1 . A method for inhibiting differentiation of adipocytes comprising administering an effective amount coumestrol or a bean extract comprising coumestrol to a subject in such need to activate mitochondria. 
     
     
         2 . The method according to  claim 1 , wherein the coumestrol or bean extract comprising coumestrol prevents or improves one or more of obesity, type 2 diabetes and fatty liver. 
     
     
         3 . The method according to  claim 1 , wherein the coumestrol or bean extract comprising coumestrol prevents or improves cardiovascular diseases induced by obesity. 
     
     
         4 . The method according to  claim 3 , wherein the cardiovascular disease comprises one or more of hyperlipidemia, hypertension, angina, myocardial infarction and arteriosclerosis. 
     
     
         5 . A method for enhancing immunity comprising administering an effective amount of coumestrol or a bean extract comprising coumestrol to a subject in such need. 
     
     
         6 . The method according to  claim 5 , wherein the coumestrol or bean extract comprising coumestrol activates immune cells. 
     
     
         7 . A method for detoxifying toxic substances comprising administering an effective amount of coumestrol or a bean extract comprising coumestrol to a subject in such need to detoxify toxic substances. 
     
     
         8 . The method according to  claim 7 , wherein the coumestrol or bean extract comprising coumestrol detoxifies nicotine. 
     
     
         9 . The method according to  claim 7 , wherein the coumestrol or bean extract comprising coumestrol prevents or improves vascular diseases caused by toxic substances. 
     
     
         10 . The method according to  claim 9 , wherein the vascular disease comprises one or more of blood circulation disorder, hypertension and arteriosclerosis. 
     
     
         11 . A method for preventing or improving degenerative neurological disorders comprising administering an effective amount of coumestrol or a bean extract comprising coumestrol to a subject in such need to prevent or improve degenerative neurological disorders. 
     
     
         12 . The method according to  claim 11 , wherein the coumestrol or bean extract comprising coumestrol inhibits the action of neurotoxins. 
     
     
         13 . The method according to  claim 11 , wherein the degenerative neurological disorder comprises one or more of dementia, Alzheimer's disease and Parkinson's disease. 
     
     
         14 - 15 . (canceled)

Join the waitlist — get patent alerts

Track US2013028921A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.